hey you would think so, but strange things happen with this company, it wouldnt surprise me if they got them stoned whilst signing papers lol, all in my opinion only
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling